genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • wound care
      Circadian Rhythm

      Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing

      AI
      Antibodies

      AI-Based Strategy Boosts High-Affinity Antibody Drug Discovery

      Artificial intelligence
      Artificial Intelligence

      BenchSci Launches AI Tool to Map Disease Biology for Preclinical Drug…

      Diabetes

      Type 1 Diabetes May Be Treatable with Immunological Drug

      cancer vaccine
      Cancer

      Remodeling How Cancer Vaccines Are Designed

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      AAV (Adeno-associated virus)

      AAV Manufacturing Sees Big Opportunities in Synthetic Biology

      Antibodies

      On Demand Could Meet Requirements for Low-Volume Production

      Bioprocessing

      Corralling Complexity in the Cloud

      Bioprocessing

      U.K. to Introduce Regulations for Biomanufacturing at Point-of-Care

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Therapeutics Autoimmune Disease Drugs Page 3

Autoimmune Disease Drugs

  • Anti-Ulcerants
  • Antibacterials
  • Antibiotics
  • Anticoagulants
  • Antidiabetics
  • Antifungals
  • Antivirals
  • Autoimmune Disease Drugs
  • Biologics
  • Biosimilars
  • Cardiovascular Drugs
  • Cellular Therapeutics
  • Combination Therapies
  • Dermatologic Drugs
  • Enzyme Replacement Therapy
  • Generics
  • Hormone Replacement Therapy
  • Immuno-oncology
  • Immunotherapies
  • Lipid Regulators
  • Mental Health Drugs
  • Oncologics
  • Orphan Drugs
  • Pain
  • Protein Therapeutics
  • Psychoactive Drugs
  • Radiopharmaceuticals
  • Respiratory Drugs
  • Traditional Chinese Medications
  • Vaccines
    Random
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Autoimmune Disease Drugs

    GSK Ends Effort to Commercialize Basilea’s Eczema Drug in U.S.

    Autoimmune Disease Drugs

    Soothing Eczema by Riling Natural Killer Cells

    GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]
    Autoimmune Disease Drugs

    GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development

    Interleukin binding to its receptor
    Autoimmune Disease Drugs

    One of a ‘Kine’: Synthekine Engineers Cytokine Therapeutics to Treat Cancer and Inflammatory Disease

    Drug Discovery

    Vikram Bajaj, PhD: “Innovation Doesn’t Come from Boston and San Francisco Alone”

    Autoimmune Disease Drugs

    FDA Knocks Back Lilly/Incyte Baricitinib Weeks after RA Drug Wins EC...

    Autoimmune Disease Drugs

    Lilly, Rigel Launch Up-to-$960M Partnership to Develop RIPK1 Inhibitors

    Autoimmune Disease Drugs

    Novartis’ Sandoz Buys European Rights to Biosimilar Remicade

    Autoimmune Disease Drugs

    MicroRNA Shown to Protect Breast Cancer Stem Cells from Immune System...

    Autoimmune Disease Drugs

    Inspyr, Lewis and Clark Merge with Prodrug and Adenosine Receptor Modulator...

    Autoimmune Disease Drugs

    Citing Patient Deaths, FDA Panel Faults Safety Data for J&J Arthritis...

    Autoimmune Disease Drugs

    Cell Therapy Developer Rubius Therapeutics Raises $100M More

    Drug Discovery

    Nektar Eliminates 70% of Workforce, 500+ Jobs, in Restructuring

    Autoimmune Disease Drugs

    BMS to Acquire Padlock Therapeutics for Up to $600M

    Autoimmune Disease Drugs

    Merck & Co. Expands Pipeline in Cancer, Fibrosis, Autoimmune Diseases by...

    1234...8Page 3 of 8

    Recently Featured

    AAV Manufacturing Sees Big Opportunities in Synthetic Biology

    AAV Manufacturing Sees Big Opportunities in Synthetic Biology

    On Demand Could Meet Requirements for Low-Volume Production

    On Demand Could Meet Requirements for Low-Volume Production

    U.K. to Introduce Regulations for Biomanufacturing at Point-of-Care

    U.K. to Introduce Regulations for Biomanufacturing at Point-of-Care

    Bob Langer Answers Your Webinar Questions

    Bob Langer Answers Your Webinar Questions

    Read the Digital Edition

    GEN 2022 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up